FBLG
FibroBiologics Inc

584
Mkt Cap
$17.51M
Volume
877,774.00
52W High
$3.89
52W Low
$0.3901
PE Ratio
-1.15
FBLG Fundamentals
Price
$0.418
Prev Close
$0.4103
Open
$0.401
50D MA
$0.5418
Beta
-0.02
Avg. Volume
681,054.29
EPS (Annual)
-$0.3395
P/B
19.86
Rev/Employee
$0.00
Loading...
Loading...
FibroBiologics, Inc. engages in the development and commercialization of cell therapies. It focuses on treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The firm’s product pipeline includes CybroCell, CYMS101, CYWC628, TCB190, and CYTER915. The company was founded by Peter O’Heeron on April 8, 2021 and is headquartered in Houston, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
13

Frequently Asked Questions

What is Market Cap of FibroBiologics Inc?
What is the 52-week high for FibroBiologics Inc?
What is the 52-week low for FibroBiologics Inc?
What is FibroBiologics Inc stock price today?
What was FibroBiologics Inc stock price yesterday?
What is the PE ratio of FibroBiologics Inc?
What is the Price-to-Book ratio of FibroBiologics Inc?
What is the 50-day moving average of FibroBiologics Inc?
How many employess does FibroBiologics Inc has?

Latest FBLG News

View

Advertisement|Remove ads.

Advertisement|Remove ads.